Inovio Pharmaceuticals, Inc. is a pharmaceutical company. The provided filing excerpt is an auditor consent (Exhibit 23.1) from Ernst & Young LLP rather than a business description, so specific product and operational details are not available from this text. The company maintains multiple equity incentive plans including the 2007 Omnibus Incentive Plan, 2016 Omnibus Incentive Plan, 2022 Inducement Plan, and 2023 Omnibus Incentive Plan.
expected 2026-11-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001055726-26-000008 | EDGAR | 74K words |
| 2025-03-18 | 2024-12-31 | 0001055726-25-000012 | EDGAR | 74K words |
| 2024-03-06 | 2023-12-31 | 0001055726-24-000011 | EDGAR | 73K words |
| 2023-03-01 | 2022-12-31 | 0001055726-23-000010 | EDGAR | 81K words |
| 2022-03-01 | 2021-12-31 | 0001055726-22-000008 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001055726-21-000018 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001055726-20-000012 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001055726-19-000012 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001055726-18-000014 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001055726-17-000013 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001055726-26-000023 | EDGAR | 50K words |
| 2025-11-10 | 2025-09-30 | 0001055726-25-000063 | EDGAR | 47K words |
| 2025-08-12 | 2025-06-30 | 0001055726-25-000055 | EDGAR | 46K words |
| 2025-05-13 | 2025-03-31 | 0001055726-25-000026 | EDGAR | 44K words |
| 2024-11-14 | 2024-09-30 | 0001055726-24-000052 | EDGAR | 46K words |
| 2024-08-08 | 2024-06-30 | 0001055726-24-000046 | EDGAR | 45K words |
| 2024-05-13 | 2024-03-31 | 0001055726-24-000020 | EDGAR | 42K words |
| 2023-11-09 | 2023-09-30 | 0001055726-23-000055 | EDGAR | 51K words |
| 2023-08-09 | 2023-06-30 | 0001055726-23-000051 | EDGAR | 49K words |
| 2023-05-10 | 2023-03-31 | 0001055726-23-000030 | EDGAR | 47K words |
| 2022-11-08 | 2022-09-30 | 0001055726-22-000055 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001055726-22-000049 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-12 | 0001055726-26-000024 | EDGAR | 3K words |
| 2026-07-31 | 0001193125-26-326785 | EDGAR | 1K words |
| 2026-07-29 | 0001193125-26-323628 | EDGAR | 1K words |
| 2026-04-06 | 0001193125-26-142885 | EDGAR | 22K words |
| 2026-04-02 | 0001193125-26-138870 | EDGAR | 1K words |
| 2026-03-12 | 0001055726-26-000009 | EDGAR | 3K words |
| 2026-01-27 | 0001193125-26-024431 | EDGAR | 1K words |
| 2025-12-29 | 0001193125-25-332322 | EDGAR | 2K words |
| 2025-11-12 | 0001193125-25-275721 | EDGAR | 1K words |
| 2025-11-10 | 0001055726-25-000064 | EDGAR | 3K words |
320 total filings indexed. 288 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001055726 |
| Ticker | INO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | San Diego, California |
| Website | https://www.inovio.com |
| Listed | 1998-12-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/INO (~200 tokens, structured JSON with cryptographic provenance)